Dr Lalchandani Labs Limited (BOM:541299)
India · Delayed Price · Currency is INR 8.37
0.00 (0.00%)
At close: Jun 19, 2026
Dr Lalchandani Labs Income Statement
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Operating Revenue | 41.86 | 44.54 | 48.1 | 50.4 | 112.79 |
Other Revenue | -0 | 0 | - | - | - |
| 41.86 | 44.54 | 48.1 | 50.4 | 112.79 | |
Revenue Growth (YoY) | -6.02% | -7.39% | -4.58% | -55.31% | 15.32% |
Cost of Revenue | 24.78 | 18.12 | 31.31 | 27.01 | 46.23 |
Gross Profit | 17.08 | 26.42 | 16.78 | 23.39 | 66.56 |
Selling, General & Admin | - | 3.19 | 3.15 | 6.95 | 15.28 |
Other Operating Expenses | 16.37 | 13.99 | 8.38 | 14.22 | 26.56 |
Operating Expenses | 22.06 | 22.82 | 20.7 | 29.12 | 47.72 |
Operating Income | -4.98 | 3.6 | -3.92 | -5.73 | 18.84 |
Interest Expense | -0.17 | -0.6 | -3.63 | -8.83 | -5.47 |
Interest & Investment Income | - | 0.05 | 0.17 | 0.05 | 0.01 |
Other Non Operating Income (Expenses) | 0.02 | -0.25 | -0.21 | -1.11 | -0.5 |
EBT Excluding Unusual Items | -5.13 | 2.79 | -7.58 | -15.62 | 12.87 |
Gain (Loss) on Sale of Assets | - | 0.02 | 1.88 | - | - |
Asset Writedown | - | -0 | -0.02 | -0.01 | - |
Other Unusual Items | 6.11 | 1.21 | 11.9 | - | - |
Pretax Income | 0.98 | 4.02 | 6.18 | -15.63 | 12.87 |
Income Tax Expense | 0.34 | -0.15 | - | - | 3.54 |
Net Income | 0.64 | 4.17 | 6.18 | -15.63 | 9.33 |
Net Income to Common | 0.64 | 4.17 | 6.18 | -15.63 | 9.33 |
Net Income Growth | -84.78% | -32.44% | - | - | -7.71% |
Shares Outstanding (Basic) | 9 | 4 | 4 | 4 | 4 |
Shares Outstanding (Diluted) | 9 | 4 | 4 | 4 | 4 |
Shares Change (YoY) | 108.74% | 0.64% | -0.25% | -0.27% | 0.01% |
EPS (Basic) | 0.07 | 0.96 | 1.43 | -3.61 | 2.15 |
EPS (Diluted) | 0.07 | 0.96 | 1.43 | -3.61 | 2.15 |
EPS Growth | -92.71% | -32.87% | - | - | -7.72% |
Free Cash Flow | -10.95 | 2.12 | -3.33 | -3.04 | 9.1 |
Free Cash Flow Per Share | -1.21 | 0.49 | -0.77 | -0.70 | 2.10 |
Gross Margin | 40.81% | 59.33% | 34.89% | 46.41% | 59.01% |
Operating Margin | -11.89% | 8.09% | -8.14% | -11.36% | 16.70% |
Profit Margin | 1.52% | 9.37% | 12.84% | -31.01% | 8.28% |
Free Cash Flow Margin | -26.15% | 4.77% | -6.92% | -6.02% | 8.07% |
EBITDA | 0.71 | 8.78 | 2.33 | 0.91 | 24.72 |
EBITDA Margin | 1.70% | 19.72% | 4.84% | 1.80% | 21.91% |
D&A For EBITDA | 5.69 | 5.18 | 6.24 | 6.63 | 5.88 |
EBIT | -4.98 | 3.6 | -3.92 | -5.73 | 18.84 |
EBIT Margin | -11.89% | 8.09% | -8.14% | -11.36% | 16.70% |
Effective Tax Rate | 35.00% | - | - | - | 27.48% |
Revenue as Reported | 41.87 | 44.61 | 50.45 | 50.45 | 112.8 |
Advertising Expenses | - | 0.16 | 0.29 | 1.31 | 1.15 |